New Dosages of Inflammatory Markers for the Early Diagnosis of Nosocomial Bacterial Infections of the Newborn

N/ACompletedNCT00701948

University Hospital, Strasbourg, France240 enrolled

Overview

This study aims to evaluate new dosage of inflammatory markers or new inflammatory markers for the diagnosis of nosocomial bacterial infection. We made the hypothesis that these new dosages or new inflammatory markers could be more useful than dosage of inflammatory markers already used in clinical practice (especially the use of a combination of interleukins (6 or 8) and C-reactive protein for the management of newborns with a clinical suspicion of nosocomial bacterial infection and especially could allow to avoid excessive treatment with antibiotics

Study Type

OBSERVATIONAL

Enrollment

240

Conditions

Nosocomial Infection

Eligibility

Sex: ALLMin age: 72 HoursMax age: 90 Days

Medical Language ↔ Plain English

Inclusion Criteria: * Newborns \> 72 hours of life hospitalized in neonatal intensive or intermediate care unit presenting a clinical suspicion of NBI Exclusion Criteria: * Early post-operative period ( surgery of less than 48 hours) * Multiple malformations * Newborn already included in the study for a previous septic events * Newborn treated with antibiotics in the last 24 hours

Locations (2)

Service de Pédiatrie 2 - Hôpital d'Enfants CHU de Dijon; 10 - bld Maréchal de Lattre de Tassigny

New Dosages of Inflammatory Markers for the Early Diagnosis of Nosocomial Bacterial Infections of the Newborn

Overview

Conditions

Eligibility

Locations (2)

Outcomes

Primary Outcomes